On 01/02/2025, Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, executed multiple transactions involving the company's Class A Common Stock. Okupe first acquired 6,437 shares at $5.01 per share through the exercise of derivative securities.Subsequently, Okupe sold a total of 11,581 shares in three separate transactions on the same day. The sales were executed at prices ranging from $24.6632 to $24.7115 per share, generating approximately $285,784 in total proceeds. The largest transaction involved the sale of 9,193 shares at an average price of $24.6732.Following these transactions, Okupe's direct ownership of Hims & Hers Health Class A Common Stock decreased to 123,221 shares. The series of transactions resulted in a net reduction of 5,144 shares in the CFO's holdings.

On 01/02/2025, Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, executed multiple transactions involving the company's Class A Common Stock. Okupe first acquired 6,437 shares at $5.01 per share through the exercise of derivative securities.Subsequently, Okupe sold a total of 11,581 shares in three separate transactions on the same day. The sales were executed at prices ranging from $24.6632 to $24.7115 per share, generating approximately $285,784 in total proceeds. The largest transaction involved the sale of 9,193 shares at an average price of $24.6732.Following these transactions, Okupe's direct ownership of Hims & Hers Health Class A Common Stock decreased to 123,221 shares. The series of transactions resulted in a net reduction of 5,144 shares in the CFO's holdings.